Pulaski Medical, LLC
Pulaski Medical, LLC was paid $28.41M by Medicaid between Jan 2018 and Dec 2024, across 22 billing codes. Its largest line is H0020, Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) — 32% of everything it billed.
PULASKI, VA 24301
Next to other Community/Behavioral Health Agency providers in Virginia
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 164,315 | $1.89M | |
| 2019 | 399,370 | $3.24M | |
| 2020 | 368,384 | $4.78M | |
| 2021 | 406,289 | $5.60M | |
| 2022 | 469,850 | $4.83M | |
| 2023 | 394,218 | $4.33M | |
| 2024incomplete | 344,349 | $3.75M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 32% | 999,347 | 46,534 | $9.17M |
| G9012 | Other specified case management service not elsewhere classified | 29% | 37,970 | 34,532 | $8.33M |
| S0109 | Methadone, oral, 5 mg | 17% | 1,097,149 | 36,095 | $4.92M |
| J0574 | Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine | 8.0% | 170,524 | 6,658 | $2.27M |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 4.6% | 38,380 | 27,505 | $1.31M |
| 80305 | 4.1% | 111,349 | 42,229 | $1.17M | |
| J0575 | Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine | 2.2% | 62,969 | 2,733 | $613K |
| H0014 | Alcohol and/or drug services; ambulatory detoxification | <1% | 3,084 | 2,242 | $265K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 3,575 | 3,326 | $161K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,410 | 1,249 | $40K |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | <1% | 2,135 | 1,740 | $38K |
| J0573 | Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine | <1% | 3,736 | 279 | $25K |
10 more codes
| 82075 | <1% | 6,132 | $23K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 551 | $22K |
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) | <1% | 3,387 | $14K |
| 86580 | <1% | 2,228 | $12K | |
| J0572 | Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine | <1% | 901 | $7K |
| 99408 | <1% | 842 | $6K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 446 | $4K |
| 81025 | <1% | 566 | $3K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 74 | $3K |
| G2078 | Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.